0000899243-22-003432.txt : 20220127 0000899243-22-003432.hdr.sgml : 20220127 20220127161335 ACCESSION NUMBER: 0000899243-22-003432 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220125 FILED AS OF DATE: 20220127 DATE AS OF CHANGE: 20220127 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Orford Keith CENTRAL INDEX KEY: 0001670740 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36644 FILM NUMBER: 22563306 MAIL ADDRESS: STREET 1: CALITHERA BIOSCIENCES STREET 2: 343 OYSTER POINT BLVD, SUITE 200 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Calithera Biosciences, Inc. CENTRAL INDEX KEY: 0001496671 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 272366329 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 343 OYSTER POINT BLVD #200 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-870-1000 MAIL ADDRESS: STREET 1: 343 OYSTER POINT BLVD #200 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-01-25 0 0001496671 Calithera Biosciences, Inc. CALA 0001670740 Orford Keith C/O CALITHERA BIOSCIENCES, INC. 343 OYSTER POINT BLVD. #200 SOUTH SAN FRANCISCO CA 94080 1 0 0 0 Employee Stock Option (Right to Buy) 0.44 2022-01-25 4 A 0 40000 0.00 A 2032-01-24 Common Stock 40000 40000 D 100% of the Option is initially subject to vesting pursuant to the Company's 2014 Equity Incentive Plan. The Option will vest in monthly installments as measured from November 18, 2021 over three years, until the earlier of the Option's full vesting or the reporting person ceasing to provide continuous service to the issuer. In addition, in the event of a Change in Control or a Corporate Transaction (each as defined in the plan pursuant to which the Option was granted), any unvested portion of the Option will fully vest and become exercisable as of immediately prior to the effective time of such Change in Control or Corporate Transaction, subject to the reporting person's continuous service on the effective date of such transaction. /s/ Keith Orford 2022-01-27